Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
131.12
+1.79 (+1.39%)
Streaming Delayed Price
Updated: 9:33 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina Inc
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
October 20, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings
October 19, 2023
These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year.
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
Where Illumina Stands With Analysts
October 16, 2023
Via
Benzinga
ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories
October 12, 2023
Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches
Via
Benzinga
Topics
Artificial Intelligence
Supply Chain
Exposures
Artificial Intelligence
Supply Chain
Expert Ratings for Illumina
September 28, 2023
Via
Benzinga
How Is The Market Feeling About Illumina?
September 11, 2023
Via
Benzinga
Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure
October 12, 2023
Illumina Inc (NASDAQ: ILMN) reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 11, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
Via
Benzinga
Bear Of The Day: Illumina
October 09, 2023
Illumina, the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year.
Via
Talk Markets
Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition
October 09, 2023
The European Union regulators are set to order Illumina Inc (NASDAQ: ILMN) to divest its acquisition of
Via
Benzinga
Is the Worst Over for Illumina Stock?
September 09, 2023
There's reason to believe that the future is starting to look better.
Via
The Motley Fool
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
September 06, 2023
Via
Benzinga
11 Analysts Have This to Say About Illumina
September 01, 2023
Via
Benzinga
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
October 06, 2023
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.
Via
MarketBeat
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
October 04, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
September 29, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Peering Into Illumina's Recent Short Interest
August 18, 2023
Via
Benzinga
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
September 29, 2023
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
September 27, 2023
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
September 19, 2023
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly — So Many Of Us Use It'
September 14, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said yes to The St. Joe Company (NYSE: JOE). "I’ve liked St. Joe forever," he added.
Via
Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories
September 08, 2023
Benzinga
Via
Benzinga
Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO
September 08, 2023
Activist investor Carl Icahn has thrown his support behind Illumina Inc's (NASDAQ: ILMN) new CEO, Jacob Thaysen, providing a sigh of relief for the company as it strives to recover from a contentious...
Via
Benzinga
Cathie Wood's Buying These 3 Stocks Hand Over Fist
September 08, 2023
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
Via
The Motley Fool
Why Is Illumina Stock Trading Lower Today?
September 05, 2023
Illumina Inc (NASDAQ: ILMN) shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways
Via
Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
August 22, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.
August 21, 2023
Its core revenue won't grow, and that's not even its biggest problem at the moment.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.